No patient left behind--better treatments for resistant HIV infection.
Hirschel
Bernard
B
Division of Infectious Diseases, Geneva University Hospital, Geneva 1211, Switzerland. Bernard.hirschel@hcuge.ch
Perneger
Thomas
T
D000069454:Darunavir; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000627:therapeutic use*; D019562:Viral Load
D017320:HIV Protease Inhibitors; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D013449:Sulfonamides; C451734:etravirine; D000069454:Darunavir